SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 25, 2026

SRTS

Sensus Healthcare, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed2mo ago
Insider cluster: 2 insiders, $173K total
Actionable Insight ▲ Bullish

The CEO's first open-market purchase since taking the role, combined with concentrated director buying, suggests management sees value below $3.25. With 90% analyst bullish consensus and recent insider activity accelerating, watch for upcoming earnings or product catalysts that could validate this conviction. The small market cap amplifies the signal's potential impact.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d
SRTS ▼ -9.82% at T+20d
LONG call ✗ call lost -9.82% · α vs SPY -10.80% · entry $3.36 → $3.03
Next anchor: T+60d in 23d
Latest observation: T+42 -19.20% FF3 residual α
Entry = T+0 close
Aug 25, 2026
via day close
T+1d
-2.08%
call -2.08% · α -2.11%
$3.29
settled 2mo ago
T+5d
-0.89%
call -0.89% · α -0.35%
$3.33
settled 8w ago
T+20d
-9.82%
call -9.82% · α -10.80%
$3.03
settled 5w ago
T+60d
Pending
in 23d

Price Chart

Loading chart...

Executive Summary

CEO Joseph Sardano and Director Eric Sachetta collectively purchased $271K of SRTS stock in open-market transactions over a 5-day window, representing ~0.49% of the company's $55M market cap. The cluster includes the CEO's first disclosed buy since joining and multiple director purchases, signaling insider confidence at current depressed prices.

Key Financial Metrics

Direction
buying
Total Value
$271.2K
Insiders
2

Key Facts

  • CEO Joseph Sardano purchased 20,000 shares at $3.02 on 8/20/2026 for $60,486
  • Director Eric Sachetta made three purchases totaling 65,697 shares for $210,754 between 8/20 and 8/24
  • Total insider buying of $271,240 represents 0.49% of market cap
  • All transactions were open-market purchases (code P) — no 10b5-1 plans or tax-related sales
  • No insider sales were filed in the same window

Financial Impact

Insider purchases of $271K represent ~0.49% of SRTS's $55M market cap, a modest but notable signal given CEO participation

insider ownershipmarket confidence

Risk Factors

  • SRTS is a micro-cap ($55M) with limited liquidity — insider buys may not translate to institutional follow-through
  • No disclosed catalyst — buying could be opportunistic rather than event-driven

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-SRTS-1787664425530
2 reports for SRTS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SRTS — sortable, filterable
TypeNow
Aug 25, 2026
8w ago
Insider Cluster
BULLISH ★ 6/10
$3.36 $3.03▼ −9.82%▼ −10.80%$2.82 (−16.07%)
Aug 24, 2026
9w ago
Insider Cluster
BULLISH ★ 5/10
$3.36 $3.03▼ −9.82%▼ −10.07%$2.82 (−16.07%)
Showing 2 of 2

US Market Status

Market Closed — Opens Tue (16h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 25, 2026